Key result
Diagnostic models of the pre-test probability of stable coronary artery disease showed modest discrimination (C statistic 0.49-0.87), with very few evaluating effects on clinical decision making.
Why the study?
What is the performance and clinical usefulness of validated diagnostic models for the pre-test probability of stable coronary artery disease?
Systematic Review (n=12)
What is the performance and clinical usefulness of validated diagnostic models for the pre-test probability of stable coronary artery disease?
Current diagnostic models for the pre-test probability of stable coronary artery disease have only modest discriminative ability and lack robust evidence regarding their impact on clinical decision-making or patient outcomes.
Clinicians should use existing pre-test probability models for stable CAD with caution; this leaves open their effects on decisions and outcomes.
A comprehensive search of PubMed and Embase was performed in January 2015 to examine the available literature on validated diagnostic models of the pre-test probability of stable coronary artery disease and to describe the characteristics of the models. Studies that were designed to develop and validate diagnostic models of pre-test probability for stable coronary artery disease were included. Data regarding baseline patient characteristics, procedural characteristics, modeling methods, metrics of model performance, risk of bias, and clinical usefulness were extracted. Ten studies involving the development of 12 models and two studies focusing on external validation were identified. Seven models were validated internally, and seven models were validated externally. Discrimination varied between studies that were validated internally (C statistic 0.66-0.81) and externally (0.49-0.87). Only one study presented reclassification indices. The majority of better performing models included sex, age, symptoms, diabetes, smoking, and hyperlipidemia as variables. Only two diagnostic models evaluated the effects on clinical decision making processes or patient outcomes. Most diagnostic models of the pre-test probability of stable coronary artery disease have had modest success, and very few present data regarding the effects of these models on clinical decision making processes or patient outcomes.
No takes yet. Share an insight, caveat, or question.
He et al. (2017) conducted a systematic review in Stable coronary artery disease (n=12). Diagnostic models of pre-test probability was evaluated on Model discrimination (C statistic) (C statistic 0.49-0.87). Diagnostic models of the pre-test probability of stable coronary artery disease showed modest discrimination (C statistic 0.49-0.87), with very few evaluating effects on clinical decision making.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: